Related Experiment Videos
Performance of a fully automated in vitro allergy testing system
1Research & Development Dept., Hycor Biomedical, Inc., Irvine, CA, USA.
Allergologia Et Immunopathologia
|March 1, 1997
Summary
The HY.TEC EIA offers comparable performance to the Pharmacia CAP system for allergen-specific IgE testing, with improved throughput. This enzyme-linked immunoassay method is a modern tool for diagnosing allergic diseases.
Area of Science:
- Clinical Immunology
- Allergy Diagnostics
- Immunoassay Technology
Background:
- Development of non-radioisotopic methods for allergen-specific IgE quantification.
- Comparison of HY.TEC EIA with Pharmacia CAP system.
Purpose of the Study:
- Evaluate HY.TEC EIA system features and assay performance.
- Compare HY.TEC EIA against Pharmacia CAP for allergen-specific IgE determination.
Main Methods:
- Assessed calibrator range, sensitivity, detection type, solid phase, throughput, and operation mode.
- Performed 2,447 tests on both HY.TEC EIA and Pharmacia CAP systems.
- Utilized a cutoff of 0.35 IU/mL for positive sample scoring.
Main Results:
- HY.TEC EIA shows comparable general features to Pharmacia UniCAP with higher throughput.
- Intra-assay precision was 7%, and inter-assay precision ranged from 9-15%.
- HY.TEC EIA demonstrated 94.0% sensitivity and 94.4% specificity compared to CAP.
Conclusions:
- HY.TEC EIA exhibits excellent agreement with Pharmacia CAP for IgE testing.
- The system is a state-of-the-art tool for allergic disease diagnosis.
- Automation of HY.TEC EIA suits modern clinical laboratory needs.